These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 857275)

  • 21. Intra-amniotic prostaglandin F2alpha and urea for midtrimester abortion.
    Wellman L; Jacobson A
    Fertil Steril; 1976 Dec; 27(12):1374-9. PubMed ID: 1001522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First experiences with a (15S)-15-methyl prostaglandin F2alpha vaginal device for termination of early first trimester pregnancy with serial sonographic observations.
    Duenhoelter JH; Santos-Ramos R
    Prostaglandins; 1976; 12 Suppl():135-45. PubMed ID: 968062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of intramuscular injections of 15(S)-15-methyl prostaglandin F2alpha in failed abortions.
    Lauersen NH; Wilson KH
    Fertil Steril; 1977 Oct; 28(10):1044-7. PubMed ID: 561711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of extra-amniotic instillation of rivanol and PGF2alpha either separately or in combination followed by oxytocin for second trimester abortion.
    Olund A; Larsson B
    Acta Obstet Gynecol Scand; 1978; 57(4):333-6. PubMed ID: 358728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandins and abortion. II. Single extra-amniotic administration of 0.92 mg. of 15-methyl prostaglandin F2alpha in Hyskon for termination of pregnancies in weeks 10 to 20 of gestation: an international multicenter study. World Health Organization Task Force on the Use of Prostaglandins for the Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov; 129(6):597-600. PubMed ID: 920760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of 15(S)15-methyl PGF2alpha following administration via various routes for induction of abortion.
    Gréen K; Bygdeman M
    Prostaglandins; 1977 Nov; 14(5):1013-24. PubMed ID: 594383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abortifacient efficacy of intravaginal prostaglandin F2 .
    Wentz AC; Austin K; King TM
    Am J Obstet Gynecol; 1973 Jan; 115(1):27-32. PubMed ID: 4681831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1974 Sep; 120(2):273-80. PubMed ID: 4412615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a lower dose schedule of intramuscular 15(S)-15-methyl prostaglandin F2 alpha for induction of early midtrimester abortion.
    Rajan R; Subhadra NM; Sarada AK; Usha DL; John R
    J Obstet Gynaecol India; 1979 Feb; 29(1):38-43. PubMed ID: 12326934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of intravaginal 15 methyl prostaglandin F2alpha methyl ester in first and second trimester abortion.
    Dillon TF; Mootabar H; Phillips LL; Risk A
    Prostaglandins; 1976; 12 Suppl():81-98. PubMed ID: 968067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of silastic vaginal device containing (15S)-15 methyl prostaglandin F2 alpha methyl ester for early first trimester pregnancy termination.
    Robins J
    Prostaglandins; 1976; 12 Suppl():123-34. PubMed ID: 968061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of longacting paracervical block anesthesia on the abortifacient efficacy of intra-amniotic PGF2alpha and hypertonic saline.
    Ragab MI; Edelman DA; Laufe L
    Acta Obstet Gynecol Scand; 1978; 57(4):327-31. PubMed ID: 358727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midtrimester abortion with urea, prostaglandin F2alpha, laminaria, and oxytocin. A new regimen.
    Wilson WB
    Obstet Gynecol; 1978 Jun; 51(6):699-701. PubMed ID: 662249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early first-trimester abortion induction by Silastic vaginal devices for continuous release of 15(S)=15-methyl prostaglandin F2alpha methyl ester.
    Robins J
    Fertil Steril; 1977 Oct; 28(10):1048-55. PubMed ID: 561712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The abortifacient effects of a newly developed vaginal silastic device impregnated with an 0.5% concentration of 15(S)-15-methyl-prostaglandin F2alpha methyl ester in the first trimester.
    Lauersen NH; Wilson KH
    Contraception; 1976 Jun; 13(6):697-705. PubMed ID: 1277841
    [No Abstract]   [Full Text] [Related]  

  • 36. Midtrimester abortion using prostaglandin F2alpha, oxytocin, and laminaria.
    Engel T; Greer B; Kochenour N; Droegemueller W
    Fertil Steril; 1973 Aug; 24(8):565-8. PubMed ID: 4718913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramuscular administration of 15(S)-15-methylprostaglandin E2-methyl ester for induction of abortion.
    Brenner WE; Dingfelder JR; Staurovsky LG; Kumarasamy T; Grimes DA
    Am J Obstet Gynecol; 1974 Nov; 120(6):833-6. PubMed ID: 4429093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-amniotic prostaglandin F2 alpha to induce midtrimester abortion.
    Corson SL; Bolognese RJ; Merola J
    Am J Obstet Gynecol; 1973 Sep; 117(1):27-34. PubMed ID: 4722375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL).
    Sher G; Katz M
    Acta Obstet Gynecol Scand; 1978; 57(3):223-5. PubMed ID: 665164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of intramuscular prostaglandin for failure of mid-trimester abortion by another method.
    Schwallie PC; Huang DC; Turner LF
    Contraception; 1980 Dec; 22(6):623-42. PubMed ID: 7214910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.